MENU
+Compare
IVEVF
Stock ticker: OTC
AS OF
Oct 17 closing price
Price
$4.30
Change
+$0.12 (+2.87%)
Capitalization
606.42M

IVEVF INVENTIVA SA Forecast, Technical & Fundamental Analysis

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation... Show more

IVEVF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for IVEVF with price predictions
Oct 17, 2025

IVEVF's RSI Oscillator is staying in overbought zone for 2 days

Watch for a price pull-back in the near future.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Bullish Trend Analysis

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (24.226). P/E Ratio (0.000) is within average values for comparable stocks, (54.529). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.181). Dividend Yield (0.000) settles around the average of (0.036) among similar stocks. P/S Ratio (23.923) is also within normal values, averaging (349.660).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. IVEVF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IVEVF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
IVEVF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
50 rue de Dijon
Phone
+33 380447500
Employees
123
Web
https://www.inventivapharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NWHQX36.340.12
+0.33%
Nationwide Bailard Tech & Sci M
EGOCX19.290.05
+0.26%
Allspring Large Cap Core C
PFGRX36.820.03
+0.08%
Victory Pioneer Fundamental Growth R
EMCAX68.110.03
+0.04%
Empiric Class A
TSMEX16.36-0.05
-0.30%
Nuveen Quant Small/Mid Cap Eq A

IVEVF and Stocks

Correlation & Price change

A.I.dvisor tells us that IVEVF and DTIL have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IVEVF and DTIL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IVEVF
1D Price
Change %
IVEVF100%
+2.87%
DTIL - IVEVF
32%
Poorly correlated
+3.92%
MIST - IVEVF
28%
Poorly correlated
-1.52%
IDRSF - IVEVF
21%
Poorly correlated
N/A
INTI - IVEVF
17%
Poorly correlated
N/A
INNMF - IVEVF
15%
Poorly correlated
N/A
More